4QB3 image
Entry Detail
PDB ID:
4QB3
Title:
Crystal structure of the first bromodomain of human BRD4 in complex with Olinone
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2014-05-06
Release Date:
2015-04-22
Method Details:
Experimental Method:
Resolution:
0.94 Å
R-Value Free:
0.15
R-Value Work:
0.13
R-Value Observed:
0.13
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Bromodomain-containing protein 4
Mutations:no
Chain IDs:A
Chain Length:127
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression.
Chem.Biol. 21 841 854 (2014)
PMID: 24954007 DOI: 10.1016/j.chembiol.2014.05.009

Abstact

Lysine acetylation regulates gene expression through modulating protein-protein interactions in chromatin. Chemical inhibition of acetyl-lysine binding bromodomains of the major chromatin regulators BET (bromodomain and extraterminal domain) proteins has been shown to effectively block cell proliferation in cancer and inflammation. However, whether selective inhibition of individual BET bromodomains has distinctive functional consequences remains only partially understood. In this study, we show that selective chemical inhibition of the first bromodomain of BET proteins using our small-molecule inhibitor, Olinone, accelerated the progression of mouse primary oligodendrocyte progenitors toward differentiation, whereas inhibition of both bromodomains of BET proteins hindered differentiation. This effect was target specific, as it was not detected in cells treated with inactive analogs and independent of any effect on proliferation. Therefore, selective chemical modulation of individual bromodomains, rather than use of broad-based inhibitors, may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.

Legend

Protein

Chemical

Disease

Primary Citation of related structures